Gladiolin

Gladiolin is an antibiotic produced by bacterium Burkholderia gladioli. The discovery of gladiolin was announced in May 2017.[1]

Gladiolin is seen as a potential treatment of drug-resistant tuberculosis.[2]

References

  1. ↑ "Discovery and Biosynthesis of Gladiolin: A Burkholderia gladioli Antibiotic with Promising Activity against Mycobacterium tuberculosis". J. Am. Chem. Soc. May 22, 2017. doi:10.1021/jacs.7b03382. Retrieved 24 June 2017.
  2. ↑ "Treating antibiotic-resistant TB". Cardiff University. 23 June 2017. Retrieved 24 June 2017.
This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.